In-depth analysis of U.S.-listed stocks, each scored on quality, growth, and valuation. Every piece breaks down the fundamentals – profitability, balance-sheet strength, and entry timing – behind a transparent Buy, Hold, or Sell signal, so you can see exactly why a company screens the way it does.
Eli Lilly and Company stock analysis: 38.6% revenue growth, a two-year high and a 46.15 P/E. See how the scores lead to a Hold signal.
Alphabet Inc. stock analysis: 24.7% revenue growth and a 14.94 P/E, but negative free cash flow. See the Quality, Growth and Opportunity scores.
MaxLinear, Inc. stock analysis: revenue up 72.4% but net margin at -4.5%. See how Quality, Growth and Opportunity scores produce a Hold signal.
UnitedHealth Group Incorporated stock analysis: a 7.4% free cash flow yield and 22.74 P/E, but revenue is down 0.4%. See the Hold signal explained.
Apple Inc. stock analysis: 31.1% operating margin and $105.7B free cash flow, but a P/E of 38.91 at a two-year high. See the Hold signal explained.
Relay Therapeutics, Inc. stock analysis: $117M cash burn, $10M revenue and a two-year high. See what the Quality, Growth and Opportunity scores show.
Arm Holdings plc stock analysis: 27.1% revenue growth and a 97.4% gross margin against a 200.71 P/E and falling earnings. Model signal: Hold.
Streetbriefs.com deliver you data-driven insights on the stock market, specializing in fundamental analysis for tech, growth, and high-dividend equities. By bridging rigorous data science with accessible market briefs, our mission is to empower investors to confidently build, analyze, and rebalance smarter portfolios.
@2026 – All Right Reserved.